BioNTech - Asia Tech Wire

BioNTech

2024.12.27

20:24

Market news: BioNTech reached a settlement agreement with the National Institutes of Health and will pay US$791.5 million.

2024.07.24

09:43

Triastek, BioNTech to develop oral RNA drugs based on 3D printing

2023.10.13

03:38

Medilink Therapeutics, BioNTech agree to partner on next generation ADC drug

Asian Tech Press (Oct 13) -- Chinese biotech firm Medilink Therapeutics and German company BioNTech SE have entered into a collaboration to develop a next-generation ADC drug.

2022.01.25

13:01

Pfizer & BioNTech Initiate Clinical Trials on Vaccine Targeting Omicron

Asian Tech Press (Jan 25) -- Pfizer and BioNTech have reportedly launched clinical trials on a Covid-19 vaccine targeting the Omnicron strain. The two pharmaceutical companies said they began enrolling adults aged 18 to 55 in the United States and South Africa to examine the vaccine's safety, tolerability, and the immune response it produces.

2022.01.06

03:49

U.S. CDC recommends Pfizer-BioNTech COVID-19 booster for ages 12-15

Asian Tech Press (Jan 6) -- The U.S. Centers for Disease Control and Prevention (CDC) recommended on Wednesday Pfizer-BioNTech COVID-19 booster doses for ages 12 to 15 years.

2021.12.31

09:25

U.S. FDA said to approve Pfizer-BioNTech COVID-19 booster for ages 12-15

Asian Tech Press (Dec 31) -- The U.S. Food and Drug Administration (FDA) plans to approve the use of Pfizer-BioNTech COVID-19 vaccine booster shot in children aged 12 to 15 next Monday, according to the New York Times, citing sources familiar with the matter.

2021.12.20

09:45

Pfizer-BioNTech COVID-19 vaccine gets nod for ages 5-11 in Thailand

Asian Tech Press (Dec 20) -- Thailand's Food and Drug Administration (FDA) said Monday that it has approved the use of Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11 years.

2021.12.15

08:39

HKU study shows 2-dose course of Pfizer, Sinovac vax inadequate against Omicron

Asian Tech Press (Dec 15)-- Two doses of the Pfizer-BioNTech or Sinovac COVID-19 vaccine are inadequate against the Omicron variant, and a third dose is recommended as soon as possible, according to research released Tuesday by the University of Hong Kong (HKU).

2021.12.10

10:02

U.S. FDA approves Pfizer-BioNTech COVID-19 booster for 16- and 17-year-olds

Asian Tech Press (Dec 10) -- The U.S. Food and Drug Administration (FDA) approved on Thursday a booster dose of the COVID-19 vaccine co-developed by Pfizer Inc. and German company BioNTech SE for 16- to 17-year-olds.

2021.12.08

09:20

Pfizer-BioNTech COVID-19 vaccine less effective against Omicron, SA study shows

Asian Tech Press (Dec 8) -- The Omicron variant can partially evade protection from two doses of Comirnaty, the Pfizer-BioNTech COVID-19 vaccine, according to a new study from South Africa posted Tuesday.

2021.11.01

08:30

UAE approves Pfizer-BioNTech COVID-19 vaccine for ages 5-11

Asian Tech Press (Nov 1) -- The UAE's Ministry of Health and Prevention has approved the use of Pfizer-BioNTech COVID-19 vaccine for children aged 5-11 years, Emirates News Agency (WAM) reported on Sunday.

2021.09.02

04:45

Fosun Pharma says first shipment of mRNA COVID-19 vaccine arrives in Taiwan

Asian Tech Press (Sep 2) -- BioNTech partner Fosun Pharma said on Thursday that the first shipment of mRNA COVID-19 vaccine arrived in Taiwan.

2021.08.24

07:32

BioNTech partner Fosun sells over $77 mln of mRNA COVID-19 vaccine in H1 2021

Asian Tech Press (Aug 24) -- Fosun Pharma has sells over $77 million of mRNA COVID-19 vaccine in the first half of the year.

2021.08.13

05:51

BioNTech says it has made delivery schedule with Taiwan for COVID-19 vaccine

Asian Tech Press -- BioNTech SE (BNTX: NASDAQ GS), the German pharmaceutical company that produces the BNT162b2 vaccine, said it has made a delivery schedule with Taiwan and will ship the vaccine to Taiwan as soon as the procedures are completed, Taiwan's Central News Agency (CNA) reported Friday.

2021.07.19

09:31

860k BioNTech vaccine arrives in Hong Kong

Asian Tech Press -- The latest batch of about 860,000 doses of COVID-19 vaccine, developed by BioNTech and Fosun Pharma, has arrived in Hong Kong on the same day, the Hong Kong government said in a release on Sunday.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Tesla (TSLA.O) Model 3/Y production in the fourth quarter of 2024 was 436,718 units.
                            2025-01-02

                                    Tesla (TSLA.O) shares fell 2.7% in pre-market trading.
                            2025-01-02